Ultralente insulin treatment of transient neonatal diabetes mellitus.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 8636827.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In an infant with transient neonatal diabetes mellitus, control of the blood glucose concentration was attained with ultralente insulin treatment, without any episodes of hypoglycemia. We recommend subcutaneous injection of ultralente insulin, rather than lente or isophane (NPH) insulin, to avoid hypoglycemia during the treatment of transient neonatal diabetes mellitus.
Medical subject headings
- Diabetes Mellitus
- Insulin, Long-Acting